Literature DB >> 27429798

Classifications for Proliferative Vitreoretinopathy (PVR): An Analysis of Their Use in Publications over the Last 15 Years.

Salvatore Di Lauro1, Mustafa R Kadhim2, David G Charteris2, J Carlos Pastor1.   

Abstract

Purpose. To evaluate the current and suitable use of current proliferative vitreoretinopathy (PVR) classifications in clinical publications related to treatment. Methods. A PubMed search was undertaken using the term "proliferative vitreoretinopathy therapy". Outcome parameters were the reported PVR classification and PVR grades. The way the classifications were used in comparison to the original description was analyzed. Classification errors were also included. It was also noted whether classifications were used for comparison before and after pharmacological or surgical treatment. Results. 138 papers were included. 35 of them (25.4%) presented no classification reference or did not use any one. 103 publications (74.6%) used a standardized classification. The updated Retina Society Classification, the first Retina Society Classification, and the Silicone Study Classification were cited in 56.3%, 33.9%, and 3.8% papers, respectively. Furthermore, 3 authors (2.9%) used modified-customized classifications and 4 (3.8%) classification errors were identified. When the updated Retina Society Classification was used, only 10.4% of authors used a full C grade description. Finally, only 2 authors reported PVR grade before and after treatment. Conclusions. Our findings suggest that current classifications are of limited value in clinical practice due to the inconsistent and limited use and that it may be of benefit to produce a revised classification.

Entities:  

Year:  2016        PMID: 27429798      PMCID: PMC4939352          DOI: 10.1155/2016/7807596

Source DB:  PubMed          Journal:  J Ophthalmol        ISSN: 2090-004X            Impact factor:   1.909


1. Introduction

Proliferative vitreoretinopathy (PVR) remains the major complication after retinal detachment surgery [1-3]. PVR was identified as an independent clinical entity in 1983 by the Retina Society Terminology Committee and a classification was created [4], based on the condition formerly named “massive vitreous traction” or “massive periretinal proliferation” [5-7]. This classification divided PVR into four stages, A, B, C, and D, apparently by increasing its severity, from minimal to massive PVR (Table 1). Nevertheless, this classification had numerous limitations. It did not consider the location of the vitreoretinal traction and the magnitude of the contraction. In addition, some of the stages provide a false idea of severity; for instance, D4 caused by a localized epiretinal membrane could be more easily treated by surgery than a C1 caused by intraretinal changes [8, 9]. In 1989, the Silicone Study Group introduced a new classification [10] including some characteristics, such as the location, anterior or posterior, and the type of contraction (Table 2). Classification was then updated in 1991 [11] according to modifications proposed by the Silicone Study Group and also by other authors [12] (Table 3). This classification appears to be difficult to use in clinical practice and may not offer any special advantage for decision-making in relation to the treatment of the disease. Moreover, the classifications might have prevented advances in the understanding of the disease pathogenesis. For instance, because the Retina Society Committee defined PVR as a “proliferative disease,” many treatments based on the inhibition of cell proliferation were developed for more than 20 years, none of which appears to have produced a significant clinical advance. Therefore, a review of both the classification and the pathogenesis of PVR appears to be appropriate to aid the development of new treatments [3].
Table 1

Classification from the Retina Society Terminology Committee (1983) [4]. This classification subdivided PVR into four stages, A, B, C, and D, apparently increasing in severity, from minimal to massive PVR. Modified from The Retina Society Terminology Committee, [4].

Retina Society Terminology Committee (1983)
GradeClinical signs
A (minimal)Vitreous haze and pigment clumps

B (moderate)Surface retinal wrinkling, rolled edges of the retinal, retinal stiffness, and vessel tortuosity

C (marked)Full-thickness fixed retinal folds in
(i) C-1(i) one quadrant,
(ii) C-2(ii) two quadrants,
(iii) C-3(iii) three quadrants

D (massive) Fixed retinal folds in four quadrants that result in
(i) D-1(i) a wide funnel shape,
(ii) D-2(ii) a narrow funnel shape,
(iii) D-3(iii) closed funnel without view of the optic disc
Table 2

Silicone Study Classification (1989). This classification scheme included proliferative membranes in the preequatorial region and on the vitreous base (anterior PVR). Attention was paid to the quantitative assessment of PVR (number of clock hours of the retina involved by membranes). Minimal (grade A) and moderate (grade B) classifications remained unchanged, but grades C and D were replaced by grades P and A (posterior and anterior forms). Moreover, grades P and A were further defined by the presence of “types” of contraction. The extension of each grade was assessed by the number of clock hours of the involved retina. Modified from [10].

Silicone Study Classification (1989)
Grade and typeClinical signs
AVitreous haze and pigment clumps

BSurface retinal wrinkling, rolled edges of the retinal, retinal stiffness, and vessel tortuosity

PP1: 1 quadrant (1–3 clock hours)P2: 2 quadrants (4–6 clock hours) P3: 3 quadrants (7–9 clock hours)P4: 4 quadrants (10–12 clock hours) (i) Type 1 (focal)(ii) Type 2 (diffuse)(iii) Type 3 (subretinal)Starfolds and/or diffuse Contraction in posterior retina and/or subretinal membrane in posterior retina (i) Starfold(ii) Confluent irregular retinal folds in posterior retina; remainder of retina drawn posterior; optic disc that may not be visible(iii) “Napkin ring” around disc or “clothesline” elevation of retina

AA1: 1 quadrant (1–3 clock hours)A2: 2 quadrants (4–6 clock hours) A3: 3 quadrants (7–9 clock hours)A4: 4 quadrants (10–12 clock hours)(i) Type 4 (circumferential) (ii) Type 5 (perpendicular) (iii) Type 6 (anterior)Circumferential and/or perpendicular and/or anterior traction in anterior retina (i) Irregular retinal folds in the anterior retina; series of radial folds more posteriorly; peripheral retina within vitreous base stretched inward(ii) Smooth circumferential fold of retina at insertion of posterior hyaloids(iii) Circumferential fold of retina at insertion of posterior hyaloids pulled forward; trough of peripheral retina anteriorly; ciliary processes stretched with possible hypotony; iris retracted

Quadrants refer to the circumferential area of retina directly involved in contraction. One quadrant, 1–3 clock hours; two quadrants, 4–6 clock hours; three quadrants, 7–9 clock hours; and four quadrants, 10–12 clock hours. Clock hours need not necessarily be contiguous.

Table 3

The updated Retina Society Classification (1991). The revised classification incorporated changes proposed by the Silicone Study Group [10] and modifications proposed also by other authors [12]. Three grades of supposed increasing severity were described, emphasizing the posterior and anterior locations of proliferation. The new classification kept grades A and B, modified grade C, and eliminated grade D. According to the Silicone Study Classification, a more detailed description of grade C (posterior and anterior) PVR was made by adding the types of contraction, the extent of which was detailed by using clock hours instead of quadrants. Modified from [11].

The updated Retina Society Classification [11]
Grade and typeClinical signs
AVitreous haze, pigment clumps, and pigment clusters on inferior retina

BWrinkling of inner retinal surface, retinal stiffness, vessel tortuosity, rolled and irregular edge of retinal break, and decreased mobility of vitreous

CP (posterior)(i) Type: (a) Focal (b) Diffuse (c) SubretinalFull-thickness retinal folds or subretinal strands posterior to equator (1–12 clock hours involvement)(i) Starfolds posterior to vitreous base(ii) Confluent starfolds posterior to vitreous base; optic disc that may not be visible(iii) Proliferation under the retina; annular strand near disc; linear strands; moth-eaten-appearing sheets

CA (anterior) (i) Type: (a) Circumferential (b) AnteriorFull-thickness retinal folds or subretinal strands anterior to equator (1–12 clock hours involvement), anterior displacement, and condensed vitreous strands(i) Retina contraction inwards at the posterior edge of the vitreous base; with central displacement of the retina; peripheral retina stretched; posterior retina in radial folds(ii) Snterior contraction on the retina at the vitreous base; ciliary body detachment and epiciliary membrane; iris retraction
There is a clinical impression that over the last 15 years clinicians have abandoned current PVR classifications. Thus, the purpose of this study has been to evaluate the current use of PVR classifications in papers dealing with clinical practice and therapy as an indirect measure of the degree of usefulness of existing classifications.

2. Methods

A search in PubMed for papers published between January 2000 and January 2014 was undertaken by two independent researchers. The basic term “proliferative vitreoretinopathy therapy” has been used. Inclusion criteria comprised human studies published in English, French, and Spanish on PVR or retinal detachment with specific mention to PVR. Prospective randomized and nonrandomized clinical studies, retrospective clinical studies, short series, and pilot studies were included. A manual search of related articles was also performed through references reported in each article. Outcome parameters were reported PVR classification, if any, and reported PVR grades. We also analyzed how the different authors interpreted the classifications, comparing the results they provided with the original description. Therefore, we investigated if they used all the characteristics (grade [A, B, C], PVR localization, extension in hours, and type) of the updated Retina Society Classification or if they were used only partially. Classification errors were also included. Furthermore, it was also noted whether classifications were used both before and after an eventual PVR pharmacological or surgical treatment. Data were extracted using a custom-made data sheet performed with agreement between authors.

3. Results

Preliminary search identified a total of 219 publications, 81 of which were eliminated as they did not fulfill the inclusion criteria. Thus, 138 publications were finally included and analyzed. 35 articles (25,4%) did not undergo detailed analysis because there was no reference to the type of PVR classification used by the authors or because no classification was used (generic terms such as initial or severe PVR or simply PVR were adopted, without using any grading system). 103 publications (74,6%) used standardized PVR classifications and they were analyzed in detail. The most used classification was the updated Retina Society Classification [11] (58 cites; 56,3%), followed by the first Retina Society Classification [4] (35 cites; 33,9%). 4 publications (3,8%) used the Silicone Study Classification (Table 4) [10]. In addition, 3 authors (2,9%) used modified or customized classifications [13-15]. In 4 publications (3,8%), errors in the stated classification were identified [13, 16–18]: in two papers [16, 18], the authors cite the updated Retina Society (‘91) but in fact they used the first Retina Society Classification (‘83), Koerner et al., after citing the updated Retina Society Classification used a customized one [13], and Roldán-Pallarés et al. cite the two Retina Society Classifications at the same time [17].
Table 4

Distribution of the used classifications for each year in papers published between January 2000 and January 2014. No data are shown about 2014 because there were no papers published at this time.

Year of publication Retina Society Classification (1983) Silicone Study Classification (1989)Updated Retina Society Classification (1991)
2000 410
2001103
2002 602
2003201
2004106
2005504
2006401
2007117
20083110
2009006
20103010
2011202
2012100
2013216

Tot.: 35Tot.: 4Tot.: 58
Among the papers using the updated Retina Society Classification, the most documented was grade C PVR (48 articles, 83%), while grades B and A were less frequently documented (15 (26%) and 7 (12%) articles, resp.). Of the publications documenting only C grade, the classification of subtypes was infrequently used. In 5 of 48 publications (10,4%), there was a full C grade description in terms of localization (anterior or posterior), extension (in clock hours), and type (focal, diffuse, subretinal, circumferential, or anterior displacement). A similar finding was observed when authors used the first Retina Society Classification (35 papers): only C and D grades were frequently reported (27 and 10 papers, resp.), while grades A and B were infrequently used (4 and 7 articles, resp.). When the Silicone Study Classification was used, only grade C was mentioned (in 2 out of 4 articles). Finally, there were 2 publications (1,9%) in which the standard classifications were used to assess changes in PVR status after any treatment, reporting PVR grade before and after it [19, 20]. The remaining authors used the classifications only to describe PVR status, rather than using them to analyze the improvement or worsening of the previous stage after the applied treatment.

4. Discussion

Classifications of PVR were developed to provide clinicians with a useful tool to compare results of treatments. They are, to date, purely descriptive and do not reflect the pathobiology of this complex vitreoretinal disease. The original classification of 1983 [4], which was relatively simple to use, induces errors in the estimating severity in some cases. As mentioned, D grades were based on the ophthalmoscopic appearance of the detached retina, and experience demonstrated that some of these cases could be relatively easily solved by peeling localized epiretinal membranes although, in some cases, classified as C, intraretinal severe changes prevent reattachment, unless complicated surgical techniques were used. Subsequent classifications [10, 11] were more detailed and therefore more complicated to use on a routine basis. They incorporated the anterior PVR forms, which add severity to the case, but until now no one has incorporated the intraretinal changes, observed in many surgical retinal samples [8, 9], which may prevent the anatomical reattachment of the retina and require retinectomy. Another important limitation is that they do not provide information on the activity of the process, although it has been observed that PVR progresses through several stages [1-3]. This may be crucial in estimating the risk of reproliferation after surgery or when surgeons schedule removing silicone oil, and no data on the chronology of events is included in any classification. Furthermore, current classifications are not prognostic and do not correlate with visual prognosis or anatomical success after surgical treatment. Moreover, some of these classifications can be difficult to use in clinical practice, due to their complexity (grade, localization, extension, type, etc.) and because they may not provide useful information they have been largely abandoned by clinicians. Our findings in this study demonstrate that, in clinical research, investigators are using them inconsistently and reporting limited observations of stages (mostly grade C). The results of this study suggest that the current classifications are of limited value. Some authors simply do not use any, preferring generic terms, such as minimal, moderate, and severe PVR [21, 22]. Furthermore, early stages of PVR (named as grades A and B), which are common to all classifications, are not used, and most authors refer only to most advanced stages, basically grade C [20, 23]. Moreover, the presence of classification errors could indicate that there is confusion concerning their use [13, 16–18]. An important relevant finding is that only a limited number of clinicians appropriately and fully use the current updated classification of 1991 [24-27], while the majority of authors avoid using the added characteristics of localization, extension, and type, limiting the description to the grade. In addition, many colleagues still use the first reported classification [4], probably because although it presents many limitations, it is easier to use compared to the last version [23, 28]. Additionally, some authors decided to use alternative classification, probably to avoid problems evaluating PVR stages [14]. The use of multiple classifications makes the efficient communication between clinicians and the comparison of different studies very problematic. As mentioned, one of the aims of this study was to evaluate the usefulness of these classifications for PVR management with surgery and other adjunctive treatments. Unfortunately, many ophthalmologists did not use the normalized classifications for comparing the outcomes using non-clearly defined terms such as PVR recurrence [29, 30].

5. Conclusions

Our findings showed the inconsistent and limited use of the current PVR classifications suggesting that it may be of benefit to produce a revised classification incorporating, if possible, the new knowledge on PVR which has been published since 1991, pointing out new potential targets for therapeutic agents distinct from those, mainly proliferative agents, targeted by the original description of this disease. Thus, it is possible that we could reduce its prevalence after retinal detachment surgery and to improve the anatomical and functional results of this disease which resists the attempts of both basic researchers and clinicians for more than 30 years.
  28 in total

1.  Pathogenesis and classification of massive periretinal proliferation.

Authors:  R Machemer
Journal:  Br J Ophthalmol       Date:  1978-11       Impact factor: 4.638

2.  The treatment of massive vitreous retraction by the separation of pre-retinal membranes using liquid silicone.

Authors:  J D Scott
Journal:  Mod Probl Ophthalmol       Date:  1975

3.  Vitrectomy without scleral buckling for proliferative vitreoretinopathy.

Authors:  Tomohito Oyagi; Kazuyuki Emi
Journal:  Retina       Date:  2004-04       Impact factor: 4.256

4.  Densiron intraocular tamponade: a case series.

Authors:  Beng Liam Lim; Brendan Vote
Journal:  Clin Exp Ophthalmol       Date:  2008-04       Impact factor: 4.207

Review 5.  Proliferative vitreoretinopathy: risk factors and pathobiology.

Authors:  J Carlos Pastor; E Rodríguez de la Rúa; Francisco Martín
Journal:  Prog Retin Eye Res       Date:  2002-01       Impact factor: 21.198

6.  A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy.

Authors:  David G Charteris; G William Aylward; David Wong; Carl Groenewald; Riaz H Y Asaria; Catey Bunce
Journal:  Ophthalmology       Date:  2004-12       Impact factor: 12.079

7.  Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening.

Authors:  J Carlos Pastor; M Carmen Méndez; Miguel A de la Fuente; Rosa M Coco; José García-Arumí; Enrique Rodríguez de la Rúa; Nieves Fernández; M Antonia Saornil; Manuel J Gayoso
Journal:  Ophthalmic Res       Date:  2006-05-04       Impact factor: 2.892

8.  Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy.

Authors:  David G Charteris; John Downie; G William Aylward; Charanjit Sethi; Philip Luthert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-04-13       Impact factor: 3.117

9.  Oxane HD vs silicone oil and scleral buckle in retinal detachment with proliferative vitreoretinopathy and inferior retinal breaks.

Authors:  Francesco Boscia; Claudio Furino; Nicola Recchimurzo; Gianluca Besozzi; Giancarlo Sborgia; Carlo Sborgia
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-03-28       Impact factor: 3.117

10.  Silicone oil tamponade in 23-gauge transconjunctival sutureless vitrectomy.

Authors:  Leonardo Bruno Oliveira; Pedro Augusto Costa Reis
Journal:  Retina       Date:  2007-10       Impact factor: 4.256

View more
  19 in total

Review 1.  Proliferative Vitreoretinopathy: A Review.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2019

2.  miRNA-124 regulates palmitic acid-induced epithelial-mesenchymal transition and cell migration in human retinal pigment epithelial cells by targeting LIN7C.

Authors:  Xiao-Dong Han; Xu-Guang Jiang; Min Yang; Wen-Jun Chen; Li-Gang Li
Journal:  Exp Ther Med       Date:  2022-06-01       Impact factor: 2.751

3.  Final anatomic and visual outcomes appear independent of duration of silicone oil intraocular tamponade in complex retinal detachment surgery.

Authors:  Maedbh Rhatigan; Elizabeth McElnea; Patrick Murtagh; Kirk Stephenson; Elaine Harris; Paul Connell; David Keegan
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

Review 4.  [Proliferative vitreoretinopathy process-To heal or not to heal].

Authors:  S Grisanti; S Priglinger; L Hattenbach
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

5.  Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy.

Authors:  Brijesh Takkar; Shreyas Temkar; Nripen Gaur; Pradeep Venkatesh; Rohan Chawla; Atul Kumar
Journal:  Indian J Ophthalmol       Date:  2017-11       Impact factor: 1.848

6.  Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy.

Authors:  Guohong Zhou; Yajiang Duan; Gaoen Ma; Wenyi Wu; Zhengping Hu; Na Chen; Yewlin Chee; Jing Cui; Arif Samad; Joanne A Matsubara; Shizuo Mukai; Patricia A D'Amore; Hetian Lei
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799

7.  Protein Kinase A Inhibitor H89 Attenuates Experimental Proliferative Vitreoretinopathy.

Authors:  Yali Lyu; Wei Xu; Jieping Zhang; Mengwen Li; Qingyi Xiang; Yao Li; Tianhao Tan; Qingjian Ou; Jingfa Zhang; Haibin Tian; Jing-Ying Xu; Caixia Jin; Furong Gao; Juan Wang; Weiye Li; Ao Rong; Lixia Lu; Guo-Tong Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

8.  Antioxidant Status in the Vitreous of Eyes with Rhegmatogenous Retinal Detachment with and without Proliferative Vitreoretinopathy, Macular Hole and Epiretinal Membrane.

Authors:  Agata Pietras-Baczewska; Katarzyna Nowomiejska; Agnieszka Brzozowska; Mario Damiano Toro; Wojciech Załuska; Małgorzata Sztanke; Krzysztof Sztanke; Robert Rejdak
Journal:  Life (Basel)       Date:  2021-05-19

9.  Observer variation in quantitative assessment of retinal shortening with ultrasound in patients of total rhegmatogenous retinal detachment.

Authors:  Brijesh Takkar; Nripen Gaur; Hameed Obedulla; Ramesh Chand Chauhan; Shreyas Temkar; Pradeep Venkatesh; Rohan Chawla; Atul Kumar
Journal:  Indian J Ophthalmol       Date:  2018-08       Impact factor: 1.848

Review 10.  Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development.

Authors:  Rishika Chaudhary; Robert A H Scott; Graham Wallace; Martin Berry; Ann Logan; Richard J Blanch
Journal:  Transl Vis Sci Technol       Date:  2020-02-21       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.